Prophylaxis Versus Preemptive Therapy for Prevention of Human Cytomegalovirus Disease in Pediatric Liver Transplant Recipients

被引：0
|
作者：
Gerna, Giuseppe [1 ]
Lilleri, Daniele [1 ]
Torre, Giuliano [2 ]
机构：
[1] Policlin San Matteo, Fdn IRCSS, Serv Virol, I-27100 Pavia, Italy
[2] Osped Riuniti Bergamo, Div Pediat, I-24100 Bergamo, Italy
来源：
TRANSPLANTATION | 2009年 / 87卷 / 02期
关键词：
D O I：
10.1097/TP.0b013e3181938beb
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：306 / 307
页数：2
相关论文
共 50 条
  • [11] Cost-effectiveness of Preemptive Therapy Versus Prophylaxis in a Randomized Clinical Trial for the Prevention of Cytomegalovirus Disease in Seronegative Liver Transplant Recipients With Seropositive Donors
    Singh, Nina
    Winston, Drew J.
    Razonable, Raymund R.
    Lyon, G. Marshall
    Silveira, Fernanda P.
    Wagener, Marilyn M.
    Limaye, Ajit P.
    CLINICAL INFECTIOUS DISEASES, 2021, 73 (09) : E2739 - E2745
  • [12] PREEMPTIVE THERAPY VERSUS UNIVERSAL PROPHYLAXIS WITH VALGANCICLOVIR IN MINIMIZING THE RISK OF CYTOMEGALOVIRUS DISEASE IN KIDNEY TRANSPLANT RECIPIENTS
    Khan, Muhammad Tassaduq
    SWISS MEDICAL WEEKLY, 2019, : 19S - 19S
  • [13] PREEMPTIVE THERAPY VERSUS UNIVERSAL PROPHYLAXIS WITH VALGANCICLOVIR IN MINIMIZING THE RISK OF CYTOMEGALOVIRUS DISEASE IN KIDNEY TRANSPLANT RECIPIENTS
    Khan, Muhammad
    TRANSPLANT INTERNATIONAL, 2019, 32 : 295 - 295
  • [14] Preemptive therapy versus universal prophylaxis with ganciclovir for cytomegalovirus in solid organ transplant recipients
    Singh, N
    CLINICAL INFECTIOUS DISEASES, 2001, 32 (05) : 742 - 751
  • [15] Cytomegalovirus immunity in high-risk liver transplant recipients following preemptive antiviral therapy versus prophylaxis
    Zamora, Danniel
    Dasgupta, Sayan
    Stevens-Ayers, Terry
    Edmison, Bradley
    Winston, Drew J.
    Razonable, Raymund R.
    Mehta, Aneesh K.
    Lyon, G. Marshall
    Boeckh, Michael
    Singh, Nina
    Koelle, David M.
    Limaye, Ajit P.
    JCI INSIGHT, 2024, 9 (18)
  • [16] Preemptive therapy with intravenous ganciclovir for the prevention of cytomegalovirus disease in lung transplant recipients
    Monforte, V
    Román, A
    Gavaldà, J
    Bravo, C
    Gispert, P
    Pahissa, A
    Morell, F
    TRANSPLANTATION PROCEEDINGS, 2005, 37 (09) : 4039 - 4042
  • [17] Prophylaxis vs Preemptive Therapy for Cytomegalovirus (CMV) Disease in (D+/R-) Liver Transplant Recipients
    Bodro, Marta M.
    Llado, Laura L.
    Sabe, Nuria N.
    Niubo, Jordi J.
    Carratala, Jordi J.
    Baliellas, Carme C.
    Fabregat, Joan J.
    LIVER TRANSPLANTATION, 2011, 17 (06) : S235 - S235
  • [18] Abolition of cytomegalovirus disease with aggressive prophylaxis and preemptive therapy in mismatched lung transplant recipients
    Hopkins, P. M.
    Kermeen, F.
    Dunning, J.
    McNeil, K.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2006, 25 (02) : S174 - S174
  • [19] Prevention and preemptive therapy of posttransplant lymphoproliferative disease in pediatric liver recipients
    McDiarmid, SV
    Jordan, S
    Lee, GS
    Toyoda, M
    Goss, JA
    Vargas, JH
    Martin, MG
    Bahar, R
    Maxfield, AL
    Ament, ME
    Busutti, RW
    TRANSPLANTATION, 1998, 66 (12) : 1604 - 1611
  • [20] Preemptive therapy is not adequate for prevention of cytomegalovirus disease in pancreas-kidney transplant recipients
    Lopez-Medrano, F.
    Rueda, B.
    Lizasoain, M.
    Juan, R. San
    Folgueira, D.
    Andres, A.
    Morales, J. M.
    Jimenez, C.
    Meneu, J. C.
    Aguado, J. M.
    TRANSPLANT INFECTIOUS DISEASE, 2009, 11 (05) : 400 - 404
12345